De3 Dry Eye Ultra Pure rTG Omega 3 – Support for Dry Eyes - 2400 mg EPA & DHA – New & Improved-Burpless-3 per day serving, 2-month supply
Produktdetails
| Artikelnummer | 215719598 | Erscheinungsdatum | 2026/04/12 | Listenpreis | €51.58 | Modellnummer | 215719598 | ||
|---|---|---|---|---|---|---|---|---|---|
| Kategorie | |||||||||
- Refresh dry, irritated eyes: Our fish oil omega-3 supplements help rejuvenate the eyes and ease grittiness, dryness and burning without the fishy aftertaste; high DHA/EPA concentration helps reach optimal eye nutrition levels in 90 days*
- High absorption: Patented formula has a 3:1 EPA to DHA ratio to help improve quality of oil produced by tear glands; our distillation process removes more toxins to produce re-esterified triglyceride (rTG) omega-3, more easily absorbed by the body*
- How it works: Our omega-3 supplement helps provide eye care with just 3 softgel pills daily in the morning or night; please allow at least 90 days to begin experiencing results
- Our quality promise: Our burpless fish oil for dry eye relief is manufactured in an NSF-certified, cGMP-compliant facility in Norway; these fish oil pills are bottled, and 3rd-party tested in the USA
- Doctor recommended: PRN is part PVG (PRN Vision Group), a complete line of eye care products; more than 4,000 ophthalmologists and optometrists recommend PVG products to their patients
| UPC | 898152001668 |
|---|---|
| Color | Yellow |
| Flavor | Unflavored |
| Item Form | Capsule |
| Brand Name | PRN Physician Recommended Nutriceuticals |
| Unit Count | 180 Count |
| Dosage Form | Capsule |
| Item Weight | 0.3 Pounds |
| Manufacturer | PRN Physician Recommended Nutriceuticals |
| Container Type | Bottle |
| Number of Items | 1 |
| Product Benefits | Eye Health Support |
| Material Features | Allergen Free |
| Age Range Description | Adult |
| Primary Supplement Type | Omega-3 Fish Oil |
| Manufacturer Part Number | AMZNUSDE3-180 |
Korrektur der Produktinformationen
Wenn Sie Unvollständigkeiten oder Fehler in den Produktinformationen auf dieser Seite bemerken, nutzen Sie bitte das Korrekturformular unten.
Korrekturanfrage